Integra LifeSciences Holdings Corp (IART) stock
IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)
Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –
Integra LifeSciences total assets
Total assets on the balance sheet at the end of each period.
Integra LifeSciences's total assets was $3.51B at Sep 30, 2026. For fiscal 2025 it was $3.60B, down 10.8% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $4.04B in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.60B | -10.8% |
| FY2024 | Dec 31, 2024 | $4.04B | +6.8% |
| FY2023 | Dec 31, 2023 | $3.78B | -2.8% |
| FY2022 | Dec 31, 2022 | $3.89B | +2.8% |
| FY2021 | Dec 31, 2021 | $3.78B | +4.6% |
| FY2020 | Dec 31, 2020 | $3.62B | +9.4% |
| FY2019 | Dec 31, 2019 | $3.30B | +6.3% |
| FY2018 | Dec 31, 2018 | $3.11B | -3.2% |
| FY2017 | Dec 31, 2017 | $3.21B | +77.6% |
| FY2016 | Dec 31, 2016 | $1.81B | +1.9% |
| FY2015 | Dec 31, 2015 | $1.77B | +11.8% |
| FY2014 | Dec 31, 2014 | $1.59B | +33.2% |
| FY2013 | Dec 31, 2013 | $1.19B | +2.5% |
| FY2012 | Dec 31, 2012 | $1.16B | +1.7% |
| FY2011 | Dec 31, 2011 | $1.14B | +12.3% |
| FY2010 | Dec 31, 2010 | $1.02B | +8.4% |
| FY2009 | Dec 31, 2009 | $940.10M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.51B | -3.8% |
| Q2 FY2026 | Jun 30, 2026 | $3.56B | -2.8% |
| Q1 FY2026 | Mar 31, 2026 | $3.58B | -11.7% |
| Q4 FY2025 | Dec 31, 2025 | $3.60B | -10.8% |
| Q3 FY2025 | Sep 30, 2025 | $3.65B | -10.3% |
| Q2 FY2025 | Jun 30, 2025 | $3.67B | -10.0% |
| Q1 FY2025 | Mar 31, 2025 | $4.05B | -0.6% |
| Q4 FY2024 | Dec 31, 2024 | $4.04B | +6.8% |
| Q3 FY2024 | Sep 30, 2024 | $4.07B | +8.7% |
| Q2 FY2024 | Jun 30, 2024 | $4.07B | +7.9% |
| Q1 FY2024 | Mar 31, 2024 | $4.08B | +9.0% |
| Q4 FY2023 | Dec 31, 2023 | $3.78B | -2.8% |
| Q3 FY2023 | Sep 30, 2023 | $3.74B | -1.8% |
| Q2 FY2023 | Jun 30, 2023 | $3.78B | +0.7% |
| Q1 FY2023 | Mar 31, 2023 | $3.74B | +1.9% |
| Q4 FY2022 | Dec 31, 2022 | $3.89B | +2.8% |
| Q3 FY2022 | Sep 30, 2022 | $3.81B | +0.9% |
| Q2 FY2022 | Jun 30, 2022 | $3.75B | +1.1% |
| Q1 FY2022 | Mar 31, 2022 | $3.67B | -1.9% |
| Q4 FY2021 | Dec 31, 2021 | $3.78B | +4.6% |
| Q3 FY2021 | Sep 30, 2021 | $3.77B | +9.3% |
| Q2 FY2021 | Jun 30, 2021 | $3.71B | +9.5% |
| Q1 FY2021 | Mar 31, 2021 | $3.74B | +8.5% |
| Q4 FY2020 | Dec 31, 2020 | $3.62B | +9.4% |
| Q3 FY2020 | Sep 30, 2020 | $3.45B | +3.2% |
| Q2 FY2020 | Jun 30, 2020 | $3.39B | +3.1% |
| Q1 FY2020 | Mar 31, 2020 | $3.45B | +7.5% |
| Q4 FY2019 | Dec 31, 2019 | $3.30B | +6.3% |
| Q3 FY2019 | Sep 30, 2019 | $3.35B | +5.3% |
| Q2 FY2019 | Jun 30, 2019 | $3.29B | +3.3% |
| Q1 FY2019 | Mar 31, 2019 | $3.21B | -1.3% |
| Q4 FY2018 | Dec 31, 2018 | $3.11B | -3.2% |
| Q3 FY2018 | Sep 30, 2018 | $3.18B | +31.4% |
| Q2 FY2018 | Jun 30, 2018 | $3.19B | +51.6% |
| Q1 FY2018 | Mar 31, 2018 | $3.25B | +58.5% |
| Q4 FY2017 | Dec 31, 2017 | $3.21B | +77.6% |
| Q3 FY2017 | Sep 30, 2017 | $2.42B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.10B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.05B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.81B | – |
See a number that looks wrong?